HN2008000276A - Derivados de 5-piridazinil-1- azabiciclo [3.2.1] octano, su preparacion y su aplicacion en terapeutica - Google Patents

Derivados de 5-piridazinil-1- azabiciclo [3.2.1] octano, su preparacion y su aplicacion en terapeutica

Info

Publication number
HN2008000276A
HN2008000276A HN2008000276A HN2008000276A HN2008000276A HN 2008000276 A HN2008000276 A HN 2008000276A HN 2008000276 A HN2008000276 A HN 2008000276A HN 2008000276 A HN2008000276 A HN 2008000276A HN 2008000276 A HN2008000276 A HN 2008000276A
Authority
HN
Honduras
Prior art keywords
piridazinil
octano
therapeutics
derivatives
preparation
Prior art date
Application number
HN2008000276A
Other languages
English (en)
Spanish (es)
Inventor
Galli Frederic
Leclerc Odile
Lochead Alistair
Vache Julien
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36297201&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HN2008000276(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of HN2008000276A publication Critical patent/HN2008000276A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
HN2008000276A 2005-08-18 2008-02-18 Derivados de 5-piridazinil-1- azabiciclo [3.2.1] octano, su preparacion y su aplicacion en terapeutica HN2008000276A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0508594A FR2889847B1 (fr) 2005-08-18 2005-08-18 Derives de 5-pyridazinyl-1-azabicyclo[3.2.1]octave, leur preparation en therapeutique.

Publications (1)

Publication Number Publication Date
HN2008000276A true HN2008000276A (es) 2011-03-30

Family

ID=36297201

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2008000276A HN2008000276A (es) 2005-08-18 2008-02-18 Derivados de 5-piridazinil-1- azabiciclo [3.2.1] octano, su preparacion y su aplicacion en terapeutica

Country Status (40)

Country Link
US (3) US7476674B2 (fr)
EP (1) EP1922320B1 (fr)
JP (1) JP5249758B2 (fr)
KR (1) KR101260546B1 (fr)
CN (2) CN101291933B (fr)
AR (1) AR056461A1 (fr)
AT (1) ATE486073T1 (fr)
AU (1) AU2006281340B2 (fr)
BR (1) BRPI0614796A2 (fr)
CA (1) CA2618110C (fr)
CR (1) CR9693A (fr)
CY (1) CY1111101T1 (fr)
DE (1) DE602006017854D1 (fr)
DK (1) DK1922320T3 (fr)
DO (1) DOP2006000191A (fr)
EA (1) EA013601B1 (fr)
EC (1) ECSP088182A (fr)
ES (1) ES2354833T3 (fr)
FR (1) FR2889847B1 (fr)
HK (1) HK1125628A1 (fr)
HN (1) HN2008000276A (fr)
HR (1) HRP20110043T1 (fr)
IL (1) IL189014A0 (fr)
JO (1) JO2680B1 (fr)
MA (1) MA29913B1 (fr)
MX (1) MX2008002276A (fr)
MY (1) MY145923A (fr)
NO (1) NO20081289L (fr)
NZ (1) NZ565537A (fr)
PE (1) PE20070234A1 (fr)
PL (1) PL1922320T3 (fr)
PT (1) PT1922320E (fr)
RS (1) RS51653B (fr)
SI (1) SI1922320T1 (fr)
TN (1) TNSN08026A1 (fr)
TW (1) TWI322808B (fr)
UA (1) UA92360C2 (fr)
UY (1) UY29756A1 (fr)
WO (1) WO2007020343A1 (fr)
ZA (1) ZA200800966B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9249307B2 (en) 2011-08-16 2016-02-02 Pierce Biotechnology, Inc. Benzocyanine compounds
WO2020017587A1 (fr) 2018-07-19 2020-01-23 大日本住友製薬株式会社 Dérivé de pyridazinone
WO2021141041A1 (fr) 2020-01-07 2021-07-15 大日本住友製薬株式会社 Agent thérapeutique pour tauopathies

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786769B1 (fr) * 1998-12-04 2002-10-25 Synthelabo Derives de 2,5-diazabicyclo[2.2.1]heptane, leur preparation et leur application en therapeutique
FR2786770B1 (fr) * 1998-12-04 2001-01-19 Synthelabo Derives de 1,4-diazabicyclo[3.2.2.]nonane, leur preparation et leur application en therapeutique
US6277855B1 (en) 2000-04-21 2001-08-21 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with nicotinic acetylcholine receptor agonists
ES2223209B1 (es) 2001-12-11 2005-10-01 Esteve Quimica, S.A. Nuevas formas cristalinas del meloxicam y procedimientos para su preparacion e interconversion.
NZ524202A (en) 2000-10-13 2004-08-27 Neurosearch As Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
FR2834511B1 (fr) * 2002-01-07 2004-02-13 Sanofi Synthelabo Derives de 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, leur preparation et leur application en therapeutique
US6644511B2 (en) 2002-01-11 2003-11-11 Unilever Home & Personal Care Usa, A Division Of Conopco, Inc. Container for dispensing a dual phase fluid product

Also Published As

Publication number Publication date
WO2007020343A1 (fr) 2007-02-22
US8076340B2 (en) 2011-12-13
US8557819B2 (en) 2013-10-15
KR20080034468A (ko) 2008-04-21
HRP20110043T1 (hr) 2011-02-28
ECSP088182A (es) 2008-03-26
UY29756A1 (es) 2007-03-30
MY145923A (en) 2012-05-15
AU2006281340B2 (en) 2012-04-12
ES2354833T3 (es) 2011-03-18
FR2889847B1 (fr) 2007-10-05
DK1922320T3 (da) 2011-02-21
TW200738715A (en) 2007-10-16
CN102558177A (zh) 2012-07-11
EA200800615A1 (ru) 2008-06-30
CA2618110C (fr) 2014-02-11
AU2006281340A1 (en) 2007-02-22
PE20070234A1 (es) 2007-03-26
PL1922320T3 (pl) 2011-04-29
ATE486073T1 (de) 2010-11-15
UA92360C2 (en) 2010-10-25
PT1922320E (pt) 2011-01-19
US20090088440A1 (en) 2009-04-02
KR101260546B1 (ko) 2013-05-06
MX2008002276A (es) 2008-03-27
HK1125628A1 (fr) 2009-08-14
SI1922320T1 (sl) 2011-02-28
US7476674B2 (en) 2009-01-13
BRPI0614796A2 (pt) 2011-04-12
CN101291933A (zh) 2008-10-22
DOP2006000191A (es) 2011-11-15
TNSN08026A1 (en) 2009-07-14
US20120046298A1 (en) 2012-02-23
RS51653B (en) 2011-10-31
NZ565537A (en) 2011-04-29
NO20081289L (no) 2008-03-17
CY1111101T1 (el) 2015-06-11
US20080176855A1 (en) 2008-07-24
CA2618110A1 (fr) 2007-02-22
JP2009504714A (ja) 2009-02-05
JP5249758B2 (ja) 2013-07-31
EP1922320B1 (fr) 2010-10-27
ZA200800966B (en) 2009-04-29
MA29913B1 (fr) 2008-11-03
CN101291933B (zh) 2012-03-14
FR2889847A1 (fr) 2007-02-23
JO2680B1 (en) 2013-03-03
EA013601B1 (ru) 2010-06-30
EP1922320A1 (fr) 2008-05-21
IL189014A0 (en) 2008-08-07
TWI322808B (en) 2010-04-01
CR9693A (es) 2008-03-06
DE602006017854D1 (de) 2010-12-09
AR056461A1 (es) 2007-10-10

Similar Documents

Publication Publication Date Title
ECSP056111A (es) Derivados de 2-acilamino-4-feniltiazol, su preparación y aplicación en terapeutica
HN2006016313A (es) Derivados de amida sustituida y metodos de uso
HN2008001103A (es) Agentes citotoxicos que comprenden nuevos derivados de tomaimicina
CY1110648T1 (el) Ενωσεις τροπανιου
HN2009003402A (es) Derivados de 7-alquinil-1,8- naftiridonas y su preparacion
GT200500126A (es) Derivados de tetrahidroisoquinolilsulfonamidas, su preparacion y su utilizacion en terapeutica
WO2008017074A3 (fr) Teintures et précurseurs et leurs conjugués
UY29036A1 (es) Derivados de oxopiperidina, su preparacion y su aplicacion en terapeutica
UY29857A1 (es) Derivados de la 4-amino-quinazolina, su preparación y su aplicación en terapéutica.
CR10303A (es) "derivados de quinolina y su uso com pesticidas"
HN2008001521A (es) Dimeros de derivados de artemisinina, su preparacion y su aplicacion en terapeutica
HN2006029142A (es) Proceso
UY29040A1 (es) Procedimiento de amino-tropano, su preparación y aplicación en terapéutica
CO6290689A2 (es) Derivados de 1,2,3,4-tetrahidropirrolo[1,2]pirazina-6-carboxamidas y de 2,3,4,5-tetrahidropirrol[1,2][1,4]-diazepina -7-carboxamidas su preparacion y su aplicacion en terapeutica
CA118372S (en) Trapeze hanger
MX2007010930A (es) Formulacion de aviptadil.
HN2008000276A (es) Derivados de 5-piridazinil-1- azabiciclo [3.2.1] octano, su preparacion y su aplicacion en terapeutica
BRPI0615332A2 (pt) Composto, uso de um composto, ingrediente perfumante, e, artigo perfumado
ECSP109874A (es) Nuevos compuestos 892
NO20091386L (no) Fenyloksyanilinderivater
DOP2007000004A (es) Derivados de 2-carbamida-4-feniltiazol, su preparación y su aplicación en terapéutica
FR2907121B1 (fr) Nouveaux derives morphiniques
ATE437624T1 (de) Topische zusammensetzungen
FR2880630B1 (fr) Composition decorative
UY30368A1 (es) 2-alcoxi-3,4,5-trihidroxi-alquilamida-benzazepinas, su preparacion, composiciones que las contienen y utilizacion